The US Food and Drug Administration (FDA) has approved the humanized monoclonal antibody eculizumab (Soliris, Alexion Pharmaceuticals) for the treatment of neuromyelitis optica spectrum disorder ...
Please provide your email address to receive an email when new articles are posted on . Become familiar with antibody-mediated myelin oligodendrocyte glycoprotein and neuromyelitis optica spectrum ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results